{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["207(6)"],"submitter":["Liu Q"],"funding":["The present study was supported by National Natural Science Foundation of China","Young Clinical Talents Training Program of Chinese Society of Traditional Chinese Medicine","Project of Academic Inheritance Studio of Famous and Aged Chinese Medicine Experts in Zhejiang Province","Clinical Medical Research Project of Zhejiang Medical Association"],"journal":["British journal of haematology"],"pagination":["2617-2621"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12710174"],"repository":["biostudies-literature"],"pubmed_title":["Reduced dose prednisone plus eltrombopag for the treatment of newly diagnosed adult primary immune thrombocytopenia: A prospective, multicentre, phase 2 clinical trial."],"pmcid":["PMC12710174"],"funding_grant_id":["CYJH2024043","82174138","GZS2021022","2022ZYC-Z25"],"pubmed_authors":["Xu L","Zhou M","Xia Y","Wu L","Rong C","Dong X","Zhou P","Qiu D","Ye B","Cai J","Shou L","Liu Q","Liu S","Wu D","Zhou Y","Zhao Y","Liu W","Zhang Y","Hu H","Shen Y","Xu X","Chen S","Zhao J"],"additional_accession":[]},"is_claimable":false,"name":"Reduced dose prednisone plus eltrombopag for the treatment of newly diagnosed adult primary immune thrombocytopenia: A prospective, multicentre, phase 2 clinical trial.","description":null,"dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Dec","modification":"2026-06-06T04:13:02.786Z","creation":"2026-05-25T03:12:03.048Z"},"accession":"S-EPMC12710174","cross_references":{"pubmed":["40954566"],"doi":["10.1111/bjh.70168"]}}